Flow Traders U.S.’s NKGen Biotech, Inc. Common Stock NKGN Stock Holding History

Flow Traders U.S.’s Portfolio NKGN Stock Details NKGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-49,220	Closed	-$9K	–	1347
2025 Q1	$9K	Buy	+49,220	New	+$25.5K	﹤0.01%	855

Flow Traders U.S.'s NKGN Position: Q2 2025 in Review

Flow Traders U.S. sold out of NKGen Biotech, Inc. Common Stock (NKGN) in Q2 2025, closing a stake of 49,220 shares — an estimated $9K sold.

Flow Traders U.S. first reported a position in NKGN in Q1 2025 and held it in 1 quarter. The position peaked at $9K in Q1 2025. 0 funds tracked by Wall St. Rank hold NKGN as of Q2 2025.

Flow Traders U.S. reported no remaining NKGen Biotech, Inc. Common Stock position as of Q2 2025 after selling out during the quarter.
Flow Traders U.S. sold 49,220 NKGen Biotech, Inc. Common Stock shares in Q2 2025, an estimated $9K.
Flow Traders U.S. first reported a position in NKGen Biotech, Inc. Common Stock in Q1 2025 and held it in 1 quarter.
Flow Traders U.S.'s NKGen Biotech, Inc. Common Stock position peaked at $9K in Q1 2025.
0 funds tracked by Wall St. Rank held NKGen Biotech, Inc. Common Stock as of Q2 2025.

Based on Flow Traders U.S.'s 13F filing for Q2 2025, filed 13 Aug 2025.